At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 161 enrolled
Drug / intervention
Ergoferon +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multicentre Open Label Comparative Parallel-group Randomized Clinical Trial of Clinical Efficiency and Safety of Ergoferon in Treatment of Influenza
In Brief
A Phase 4 clinical trial evaluating Ergoferon and Oseltamivir for Influenza. Completed, enrolled 161 participants across 8 sites.
Detailed Summary
The purpose of this study is: * to assess clinical efficiency of Ergoferon for treatment of influenza * to assess safety of Ergoferon for treatment of influenza * to compare efficiency of Ergoferon and Tamiflu for treatment of influenza
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfluenza
CountriesRussia
Collaborators--
Timeline
Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2011
First PostedMar 2013
Primary CompletionApr 2014
Study CompletionOct 2014
TodayJul 2026
First PostedMar 5, 2013
Enrollment StartFeb 1, 2011
Primary CompletionApr 1, 2014
Study CompletionOct 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 13.3 years ago
Interventions
Ergoferondrug
Safety and Efficiency of Ergoferon in treatment of Influenza
Oseltamivirdrug
Safety and Efficiency in treatment of Influenza